-
-
-
-
-
-
-
Adverum Biotechnologies Reports First Quarter 2025 Financial Results and Provides Pipeline Highlights
-
-
-
-
-
-
-
Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights
-
-
-
-
-
-
-
Adverum Biotechnologies (ADVM) Tops Q2 EPS by 2c
-
-
-
-
-
-
-
Adverum Biotechnologies Reports Third Quarter 2022 Financial Results
-
-
-
-
-
-
-
Adverum Provides Update on ADVM-022 and the INFINITY Trial in Patients with Diabetic Macular Edema
-
-
-
-
-
-
-
Adverum Announces Board Slate for 2021 Annual Meeting and Reiterates Commitment to Stockholder Value Creation
-
-
-
-
-
-
-
Adverum Biotechnologies (ADVM) Misses Q2 EPS by 8c
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

